Our study aimed at validating the effect of WISP1 on osteoarthritis (OA) and the pathway involved in the WISP1-induced protection against OA. The expression of WISP1 was measured by immunohistochemical analyses. We found that WISP1 expression was shown to be upregulated within human OA cartilage compared with controls. WISP1 expression was related to knee OA severity. rhWISP1 inhibited OA chondrocyte senescence and apoptosis in vitro, which was reversed by the αvβ3 antibody and PI3K/Akt inhibitor LY294002. WISP1 overexpression induced by knee injection of LiCI could also prevent the senescence and apoptosis of rat chondrocytes. Safranin-O staining and Mankin score revealed that WISP1 overexpression can protect rat chondrocytes from degeneration. Nearly opposite results were obtained in the treatment of ICG-001 and siRNA-WISP1 in vivo. These data strongly suggest that WISP1 can protect against the senescence and apoptosis of chondrocytes via modulating the αvβ3 receptor and PI3K/Akt signaling pathway within OA. Therefore, the development of specific activators of WISP1 may present the value of an underlying OA treatment.
Get full access to this article
View all access options for this article.
References
1.
AdlerA.S., KawaharaT.L., SegalE., and ChangH.Y. (2008). Reversal of aging by NFkappaB blockade. Cell Cycle, 7, 556–559.
2.
Ben-PorathI., and WeinbergR.A. (2005). The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37:961–976.
3.
BerschneiderB., EllwangerD.C., BaarsmaH.A., ThielC., ShimboriC., WhiteE.S., et al. (2014). miR-92a regulates TGF-beta1-induced WISP1 expression in pulmonary fibrosis. Int J Biochem Cell Biol, 53, 432–441.
4.
BlasioliD.J., and KaplanD.L. (2014). The roles of catabolic factors in the development of osteoarthritis. Tissue Eng Part B Rev, 20, 355–363.
5.
BlomA.B., BrockbankS.M., van LentP.L., van BeuningenH.M., GeurtsJ., TakahashiN., et al. (2009). Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum, 60, 501–512.
6.
BrigstockD.R. (2003). The CCN family: a new stimulus package. J Endocrinol, 178, 169–175.
7.
ChenH., ShiB., FengX., KongW., ChenW., GengL., et al. (2015). Leptin and Neutrophil-Activating Peptide 2 Promote Mesenchymal Stem Cell Senescence Through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol, 67, 2383–2393.
8.
DimriG.P., LeeX., BasileG., AcostaM., ScottG., RoskelleyC., et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A, 92, 9363–9367.
9.
FernandesM.T., FernandesK.B., MarquezA.S., ColusI.M., SouzaM.F., SantosJ.P., et al. (2015). Association of interleukin-6 gene polymorphism (rs1800796). with severity and functional status of osteoarthritis in elderly individuals. Cytokine, 75, 316–320.
10.
FrenchD.M., KaulR.J., D'SouzaA.L., CrowleyC.W., BaoM., FrantzG.D., et al. (2004). WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol, 165, 855–867.
11.
GaoS.G., ZengC., LiL.J., LuoW., ZhangF.J., TianJ., et al. (2016). Correlation between senescence-associated beta-galactosidase expression in articular cartilage and disease severity of patients with knee osteoarthritis. Int J Rheum Dis, 19, 226–232.
12.
GeyerM., GrasselS., StraubR.H., SchettG., DinserR., GrifkaJ., et al. (2009). Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis Cartilage, 17, 328–335.
13.
GiancottiF.G., and RuoslahtiE. (1991). A single-chain integrin?. New Biol, 3, 525–526.
GreenhalghD.G. (1998). The role of apoptosis in wound healing. Int J Biochem Cell Biol, 30, 1019–1030.
16.
GrishkoV., XuM., HoR., MatesA., WatsonS., KimJ.T., et al. (2009). Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem, 284, 9132–9139.
17.
HouC.H., TangC.H., HsuC.J., HouS.M., and LiuJ.F. (2013). CCN4 induces IL-6 production through alphavbeta5 receptor, PI3K, Akt, and NF-kappaB singling pathway in human synovial fibroblasts. Arthritis Res Ther 15,R19.
18.
HubackovaS., NovakovaZ., KrejcikovaK., KosarM., DobrovolnaJ., DuskovaP., et al. (2010). Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling. Cell Cycle, 9, 3085–3099.
19.
HwangH.S., and KimH.A. (2015). Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci, 16, 26035–26054.
20.
InksonC.A., OnoM., KuznetsovS.A., FisherL.W., RobeyP.G., and YoungM.F. (2008). TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem, 104, 1865–1878.
21.
JianY.C., WangJ.J., DongS., HuJ.W., HuL.J., YangG.M., et al. (2014). Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo. Clin Lab, 60, 29–35.
22.
KimS.J., JuJ.W., OhC.D., YoonY.M., SongW.K., KimJ.H., et al. (2002). ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem, 277, 1332–1339.
23.
KonigshoffM., KramerM., BalsaraN., WilhelmJ., AmarieO.V., JahnA., et al. (2009). WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest, 119, 772–787.
24.
KozhemyakinaE., ZhangM., IonescuA., AyturkU.M., OnoN., KobayashiA., et al. (2015). Identification of a Prg4-expressing articular cartilage progenitor cell population in mice. Arthritis Rheumatol, 67, 1261–1273.
25.
LiuS., LiuS., WangX., ZhouJ., CaoY., WangF., et al. (2011). The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro. Aging Cell, 10, 661–674.
26.
LorenziniA., TresiniM., Mawal-DewanM., FrisoniL., ZhangH., AllenR.G., et al. (2002). Role of the Raf/MEK/ERK and the PI3K/Akt(PKB) pathways in fibroblast senescence. Exp Gerontol, 37, 1149–1156.
27.
LuS., LiuH., LuL., WanH., LinZ., QianK., et al. (2016). WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway. Eur J Pharmacol, 788, 90–97.
28.
MaC.H., LvQ., YuY.X., ZhangY., KongD., NiuK.R., et al. (2015). Protective effects of tumor necrosis factor-alpha blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritis. Braz J Med Biol Res, 48, 863–870.
29.
MatsuzakiT., MatsushitaT., TakayamaK., MatsumotoT., NishidaK., KurodaR., et al. (2014). Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann Rheum Dis, 73, 1397–1404.
30.
MullerM. (2009). Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal, 11, 59–98.
RenJ.L., PanJ.S., LuY.P., SunP., and HanJ. (2009). Inflammatory signaling and cellular senescence. Cell Signal, 21, 378–383.
33.
Takacs-BuiaL., IordachelC., EfimovN., CaloianuM., MontreuilJ., and BratosinD. (2008). Pathogenesis of osteoarthritis: chondrocyte replicative senescence or apoptosis?. Cytometry B Clin Cytom, 74, 356–362.
34.
TakayamaK., KawakamiY., LeeS., GrecoN., LavasaniM., MifuneY., et al. (2014). Involvement of ERCC1 in the pathogenesis of osteoarthritis through the modulation of apoptosis and cellular senescence. J Orthop Res, 32, 1326–1332.
35.
TilstraJ.S., RobinsonA.R., WangJ., GreggS.Q., ClausonC.L., ReayD.P., et al. (2012). NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest, 122, 2601–2612.
36.
UranoT., NarusawaK., ShirakiM., UsuiT., SasakiN., HosoiT., et al. (2007). Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women. J Bone Miner Metab, 25, 253–258.
37.
van den BoschM.H., BlomA.B., KramV., MaedaA., SikkaS., GabetY., et al. (2017). WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis. Osteoarthritis Cartilage, 25, 1900–1911.
38.
van den BoschMHJ, RamosYFM, den HollanderW., BomerN., NelissenR., BoveeJ., et al. (2019). Increased WISP1 expression in human osteoarthritic articular cartilage is epigenetically regulated and decreases cartilage matrix production. Rheumatology (Oxford), 58, 1065–1074.
39.
van der SluijsJ.A., GeesinkR.G., van der LindenA.J., BulstraS.K., KuyerR., and DrukkerJ. (1992). The reliability of the Mankin score for osteoarthritis. J Orthop Res, 10, 58–61.
WangL., GaiP., XuR., ZhengY., LvS., LiY., et al. (2015). Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway. Int J Clin Exp Pathol, 8, 298–308.
42.
WangS.X., LavertyS., DumitriuM., PlaasA., and GrynpasM.D. (2007). The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum, 56, 1537–1548.
43.
WangY., FanX., XingL., and TianF. (2019). Wnt signaling: a promising target for osteoarthritis therapy. Cell Commun Signal 17,97.
44.
WangZ., LiuY., TakahashiM., Van HookK., Kampa-SchittenhelmK.M., SheppardB.C., et al. (2013). N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence. Proc Natl Acad Sci U S A, 110, 312–317.
45.
WuC.L., TsaiH.C., ChenZ.W., WuC.M., LiT.M., FongY.C., et al. (2013). Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma. Cell Signal, 25, 2812–2822.
46.
XiaB., DiC., ZhangJ., HuS., JinH., and TongP. (2014). Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int 95:495–505.
47.
YanC.L., LiS.H., AnF.Y., LiuY.Q., XiaP.F., MaZ.M., et al. (2018). [The therapeutic effects of Yougui pill on knee osteoarthritis and the expression of Wnt signal pathway related factors in rats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 34, 177–181.
48.
YangM., ZhaoX., LiuY., TianY., RanX., and JiangY. (2013). A role for WNT1-inducible signaling protein-1 in airway remodeling in a rat asthma model. Int Immunopharmacol, 17, 350–357.
49.
ZamliZ., and SharifM. (2011). Chondrocyte apoptosis: a cause or consequence of osteoarthritis?. Int J Rheum Dis, 14, 159–166.
50.
ZhengX., XiaC., ChenZ., HuangJ., GaoF., LiG., et al. (2012). Requirement of the phosphatidylinositol 3-kinase/Akt signaling pathway for the effect of nicotine on interleukin-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. Biochem Biophys Res Commun, 423, 606–612.
51.
ZhouY., WangT., HamiltonJ.L., and ChenD. (2017). Wnt/beta-catenin signaling in osteoarthritis and in other forms of arthritis. Curr Rheumatol Rep 19,53.
52.
ZushiS., AkagiM., KishimotoH., TeramuraT., SawamuraT., and HamanishiC. (2009). Induction of bovine articular chondrocyte senescence with oxidized low-density lipoprotein through lectin-like oxidized low-density lipoprotein receptor 1. Arthritis Rheum, 60, 3007–3016.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
